Amgen Inc (AMGN) stock
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3022% above fair value
$465.67−1.39 (-0.30%)
Close on Nov 13, 2026Market cap $251.76BP/E 27.0Yield 2.07%
Amgen profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Amgen's profit margin for the twelve months ending Sep 30, 2026 was 24.1%. For fiscal 2025 it was 21.0%, against 12.2% the year before. The highest annual figure on record is 35.3% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21.0% | +8.7 |
| FY2024 | Dec 31, 2024 | 12.2% | −11.6 |
| FY2023 | Dec 31, 2023 | 23.8% | −1.1 |
| FY2022 | Dec 31, 2022 | 24.9% | +2.2 |
| FY2021 | Dec 31, 2021 | 22.7% | −5.9 |
| FY2020 | Dec 31, 2020 | 28.6% | −5.0 |
| FY2019 | Dec 31, 2019 | 33.6% | −1.8 |
| FY2018 | Dec 31, 2018 | 35.3% | +26.7 |
| FY2017 | Dec 31, 2017 | 8.7% | −24.9 |
| FY2016 | Dec 31, 2016 | 33.6% | +1.6 |
| FY2015 | Dec 31, 2015 | 32.0% | +6.3 |
| FY2014 | Dec 31, 2014 | 25.7% | −1.5 |
| FY2013 | Dec 31, 2013 | 27.2% | +2.0 |
| FY2012 | Dec 31, 2012 | 25.2% | +1.5 |
| FY2011 | Dec 31, 2011 | 23.6% | −7.1 |
| FY2010 | Dec 31, 2010 | 30.7% | −0.7 |
| FY2009 | Dec 31, 2009 | 31.5% | +4.4 |
| FY2008 | Dec 31, 2008 | 27.0% | +6.2 |
| FY2007 | Dec 31, 2007 | 20.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 37.3% | +3.6 |
| Q2 FY2026 | Jun 30, 2026 | 23.6% | +8.0 |
| Q1 FY2026 | Mar 31, 2026 | 21.1% | −0.1 |
| Q4 FY2025 | Dec 31, 2025 | 13.5% | +6.6 |
| Q3 FY2025 | Sep 30, 2025 | 33.7% | +0.4 |
| Q2 FY2025 | Jun 30, 2025 | 15.6% | +6.7 |
| Q1 FY2025 | Mar 31, 2025 | 21.2% | +22.7 |
| Q4 FY2024 | Dec 31, 2024 | 6.9% | −2.5 |
| Q3 FY2024 | Sep 30, 2024 | 33.3% | +8.2 |
| Q2 FY2024 | Jun 30, 2024 | 8.9% | −10.8 |
| Q1 FY2024 | Mar 31, 2024 | -1.5% | −48.1 |
| Q4 FY2023 | Dec 31, 2023 | 9.4% | −14.3 |
| Q3 FY2023 | Sep 30, 2023 | 25.1% | −7.2 |
| Q2 FY2023 | Jun 30, 2023 | 19.7% | −0.2 |
| Q1 FY2023 | Mar 31, 2023 | 46.5% | +22.9 |
| Q4 FY2022 | Dec 31, 2022 | 23.6% | −4.1 |
| Q3 FY2022 | Sep 30, 2022 | 32.2% | +4.3 |
| Q2 FY2022 | Jun 30, 2022 | 20.0% | −4.4 |
| Q1 FY2022 | Mar 31, 2022 | 23.7% | −7.8 |
| Q4 FY2021 | Dec 31, 2021 | 27.7% | −1.3 |
| Q1 FY2021 | Mar 31, 2021 | 27.9% | −1.7 |
| Q4 FY2020 | Dec 31, 2020 | 24.3% | −12.8 |
| Q3 FY2020 | Sep 30, 2020 | 31.5% | −4.4 |
| Q2 FY2020 | Jun 30, 2020 | 29.1% | −1.9 |
| Q1 FY2020 | Mar 31, 2020 | 29.6% | −1.9 |
| Q2 FY2019 | Jun 30, 2019 | 37.1% | −0.8 |
| Q1 FY2019 | Mar 31, 2019 | 35.8% | −5.8 |
| Q4 FY2018 | Dec 31, 2018 | 30.9% | +107.5 |
| Q3 FY2018 | Sep 30, 2018 | 31.5% | −3.5 |
| Q2 FY2018 | Jun 30, 2018 | 37.9% | +0.9 |
| Q1 FY2018 | Mar 31, 2018 | 41.6% | +3.7 |
| Q4 FY2017 | Dec 31, 2017 | -76.6% | −110.7 |
| Q3 FY2017 | Sep 30, 2017 | 35.0% | −1.6 |
| Q2 FY2017 | Jun 30, 2017 | 37.0% | +2.9 |
| Q1 FY2017 | Mar 31, 2017 | 37.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 34.2% | – |
| Q3 FY2016 | Sep 30, 2016 | 36.6% | – |
| Q2 FY2016 | Jun 30, 2016 | 34.2% | – |
See a number that looks wrong?